Journal
REGENERATIVE MEDICINE
Volume 3, Issue 2, Pages 199-215Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/17460751.3.2.199
Keywords
cellular MRI; ferumoxides-protamine sulfate; magnetic cell labeling; SPIO; stem cell tracking
Categories
Funding
- CLINICAL CENTER [ZIACL090007, Z01CL090007] Funding Source: NIH RePORTER
- Intramural NIH HHS Funding Source: Medline
Ask authors/readers for more resources
Hematopoietic, stromal and organ-specific stem cells are under evaluation for therapeutic efficacy in cell-based therapies of cardiac, neurological and other disorders. It is critically important to track the location of directly transplanted or infused cells that can serve as gene carrier/delivery vehicles for the treatment of disease processes and be able to noninvasively monitor the temporal and spatial homing of these cells to target tissues. Moreover, it is also necessary to determine their engraftment efficiency and functional capability following transplantation. There are various in vivo imaging modalities used to track the movement and incorporation of administered cells. Tagging stem cells with different contrast agents can make these cells probes for different imaging modalities. Recent reports have shown that stem cells labeled with iron oxides can be used as cellular MRI probes demonstrating the cell trafficking to target tissues. In this review, we will discuss the status and future prospect of stem cell tracking by cellular MRI for cell-based therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available